News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,603 Results
Type
Article (87476)
Company Profile (806)
Press Release (773299)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233070)
Career Advice (4140)
Deals (39800)
Drug Delivery (138)
Drug Development (91264)
Employer Resources (203)
FDA (18288)
Job Trends (17403)
News (397433)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (147)
Alzheimer's disease (1685)
Antibody-drug conjugate (ADC) (257)
Approvals (18321)
Artificial intelligence (500)
Autoimmune disease (87)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (514)
Cancer (4051)
Cardiovascular disease (347)
Career advice (3560)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (693)
Cervical cancer (33)
Clinical research (75651)
Collaboration (1410)
Company closure (4)
Compensation (942)
Complete response letters (60)
COVID-19 (2960)
CRISPR (82)
C-suite (602)
Cystic fibrosis (140)
Data (4669)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (458)
Diagnostics (7096)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98906)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133150)
Executive appointments (994)
FDA (20798)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1273)
Gene editing (174)
Generative AI (50)
Gene therapy (553)
GLP-1 (1024)
Government (5386)
Grass and pollen (7)
Guidances (351)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (54)
Infectious disease (3208)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (584)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (647)
MASH (142)
Medical device (14885)
Medtech (14910)
Mergers & acquisitions (22763)
Metabolic disorders (1169)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (63)
Neuroscience (2739)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (564)
Opinion (314)
Ovarian cancer (137)
Pain (170)
Pancreatic cancer (173)
Parkinson's disease (244)
Partnered (30)
Patents (423)
Patient recruitment (324)
Peanut (57)
People (66299)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23339)
Phase II (32834)
Phase III (24748)
Pipeline (2761)
Policy (295)
Postmarket research (3554)
Preclinical (10530)
Press Release (72)
Prostate cancer (203)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (686)
Real estate (7422)
Recruiting (79)
Regulatory (28061)
Reports (65)
Research institute (2693)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (138)
Series A (212)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1055)
Venture capital (67)
Weight loss (399)
Women's health (59)
Worklife (21)
Date
Today (133)
Last 7 days (763)
Last 30 days (2677)
Last 365 days (33553)
2025 (27139)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (305)
Arkansas (14)
Asia (51015)
Australia (8965)
California (9599)
Canada (2888)
China (921)
Colorado (406)
Connecticut (428)
Delaware (273)
Europe (117199)
Florida (1410)
Georgia (317)
Hawaii (3)
Idaho (67)
Illinois (818)
India (52)
Indiana (471)
Iowa (20)
Japan (329)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1291)
Massachusetts (7203)
Michigan (316)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2665)
New Mexico (32)
New York (2605)
North Carolina (1421)
North Dakota (10)
Northern California (4368)
Ohio (300)
Oklahoma (22)
Oregon (51)
Pennsylvania (1994)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3664)
Tennessee (150)
Texas (1512)
United States (35408)
Utah (284)
Virginia (250)
Washington D.C. (84)
Washington State (825)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,603 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neuroscience
BridgeBio Pops on Late-Stage Limb-Girdle Muscular Dystrophy Data
New interim data from a Phase III trial puts the company on track to file for FDA approval next year in an indication that not only lacks a disease-modifying treatment but suffered significant setbacks after a patient died in a clinical trial for Sarepta’s investigational gene therapy.
October 27, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Wellgistics Health Enters into Smart Contract Services Agreement with DataVault AI to Develop Patented PharmacyChain(TM) Manufacturer-to-Patient Blockchain-Enabled Tracking & Dispensing Platform for Prescription Drug Market
Powered by DataVault AI’s High-Performance Computing & Information Exchange, Data Monetization for Traditional and Compound Pharmacies is Set to Become a Reality in the $639 Billion Prescription Drug Market, with Beta Testing Expected in First Half of 2026
October 27, 2025
·
7 min read
Press Releases
Zenith Epigenetics’ ZEN-3694 Receives Orphan Drug Designation from FDA
October 27, 2025
·
6 min read
Press Releases
Lifordi Immunotherapeutics Presents Nonclinical Data on Glucocorticoid Antibody Drug Conjugate LFD-200 at ACR 2025 and Initiates Phase 1 Study in Rheumatoid Arthritis
October 27, 2025
·
1 min read
Press Releases
Envoy Medical Receives Positive Listing Determination from NASDAQ
October 27, 2025
·
7 min read
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
Rare diseases
Intellia Pauses Phase III ATTR Trials for CRISPR Gene Therapy After Life-Threatening Liver Toxicity
Intellia earlier this year reported a similar grade 4 liver enzyme elevation associated with the gene therapy nexiguran ziclumeran, though analysts at BMO Capital Markets at the time brushed it off as a “non-concern.”
October 27, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases.
October 27, 2025
·
2 min read
·
Tristan Manalac
Approvals
Bayer Gets FDA Nod for Novel Drug to Treat Hot Flashes
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
October 27, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events
October 27, 2025
·
2 min read
1 of 86,161
Next
